Trial Profile
A Study to Compare the Efficacy of Sirolimus-Eluting Stents With Biodegradable Polymer Versus Zotarolimus-Eluting Stents With Durable Polymer in Patients with Coronary Artery Disease (CAD) who Underwent Percutaneous Coronary Intervention (PCI)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Dec 2015
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary) ; Zotarolimus (Primary)
- Indications Coronary artery disease
- Focus Therapeutic Use
- Acronyms ALSTER-OCT
- 28 Dec 2015 New trial record